TTX-080

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTTX-080
Drug Alias NameTTX-080TTX080
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionHLA class I histocompatibility antigen, alpha chain G inhibitors
TargetsHLA class I histocompatibility antigen, alpha chain G
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTizona Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences IncTizona Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A